Mr. Rob Carducci reports

GLOW LIFETECH ACHIEVES WARRANT-FREE CAPITAL STRUCTURE FOLLOWING ELIMINATION OF 70 MILLION WARRANTS AND 20% REDUCTION IN FULLY DILUTED SHARES

All of Glow Lifetech Corp.'s outstanding 8.9 million share purchase warrants expired unexercised on May 29, 2026, fully eliminating the company's warrant overhang. This milestone represents another important step in Glow's continuing efforts to simplify its capital structure, reduce potential dilution and enhance long-term shareholder value.

Strengthening capital structure

The expiration of the remaining warrants follows the elimination of 41,031,673 warrants during Q1 20262 and 20,166,667 warrants during Q4 20253 through a combination of expiry and exercise. In total, Glow has eliminated more than 70 million warrants over the past eight months, significantly reducing potential dilution and simplifying its capital structure going forward.

Since the end of Q1 2025, Glow has reduced its fully diluted share count by approximately 20 per cent, driven by the expiry and exercise of warrants and stock options. These actions reflect Glow's continued commitment to disciplined capital structure management and prudent stewardship of shareholder capital.

"The elimination of our remaining warrant overhang is a positive development for shareholders, meaningfully reducing potential dilution and reflects ongoing commitment to a cleaner, more shareholder-friendly capital structure," said Rob Carducci, chief executive officer of Glow Lifetech. "Over the past year, we've taken several steps to strengthen our balance sheet and simplify our capital structure, culminating in the elimination of more than 70 million warrants and a reduction of approximately 20 per cent in our fully diluted share count. Combined with our debt-free balance sheet, strong cash balance and improving operating performance, these achievements strengthen the foundation of the business and position Glow to create long-term value for shareholders as we continue executing our growth strategy."

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

We seek Safe Harbor.